Company to view next
Generic selectors
Exact matches only
Search in title
Search in content

BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of various cancers. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. It also develops BA3021, a CAB ADC for NSCLC and Melanoma; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. The company was founded in 2007 and is based in San Diego, California.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

36

Address:

BioAtla, Inc. 11085 Torreyana Road San Diego CA 92121 United States

Website:

Home

Phone:

858-558-0708

Leave a comment

Your email address will not be published. Required fields are marked *